Luye Pharma Group has announced its intention to acquire the transdermal drug delivery systems (TDS) business of Acino by purchasing the entire issued share capital of Acino AG and Acino Supply AG for a purchase price of €245m ($268.8m).

Luye Pharma marks a significant step in its international expansion strategy and enables it to explore broader therapeutic areas through the acquisition.

MED-ART has agreed to sell its 100% stake in Q-Med, an orthopedic product developer, to EMC Instytut Medyczny S.A. (EMC Instytut), a Polish healthcare services provider, for PLN7.7m ($2m).

“Luye Pharma marks a significant step in its international expansion strategy and enables it to explore broader therapeutic areas through the acquisition.”

EMC Instytut has also signed a preliminary agreement to completely own CM Medyk Sp. z o.o., which operates under the Aktywne Centrum Zdrowia (ACZ) brand.

Steris, a cleaning validation and infection prevention solutions provider has, completed the acquisition of Medisafe Holdings, a UK-based maker of washer / disinfector equipment, for approximately £27m ($35.68m).

Effective from 22 July 2016, the acquisition provides Steris with washer manufacturing and research and development capabilities in the UK, while Medisafe’s products complement its healthcare products segment.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Fujifilm Holdings Corporation has announced that it will acquire 70% stake in Wako Pure Chemical Industries from Takeda Pharmaceutical for a purchase consideration of approximately ¥100bn ($939.85m).

Once completed, the acquisition will help Fujifilm to improve its drug development capacity and to develop partnerships with operations that utilise regenerative medical technology.